Navidea Biopharmaceuticals Inc.

AMEX: NAVBHealthcare / Biotechnology / USA
0.7200+0.0200+2.86%Vol 54 5471Y Perf -78.99%
Sep 16th, 2019 11:52
BID0.7400 ASK0.7500
Open0.7100 Previous Close0.7000
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.00 
Analyst Rating
Strong Buy 1.00
Potencial %
166.67 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
+     30.76
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Buy
Price Range Ratio 52wk %
3.33 
Earnings Date
6th Nov 2019

Today's Price Range

0.70000.7500

52wk Range

0.49007.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
22.81%
1 Month
37.25%
3 Months
2.94%
6 Months
-73.88%
1 Year
-78.99%
3 Years
-30.00%
5 Years
-46.15%
10 Years
-45.31%

Name / TickerPriceChg.Chg.%
NAVB0.72000.02002.86
AAPL219.230.48000.22
GOOG1 230.88-8.6800-0.70
MSFT136.28-1.0400-0.76
XOM73.781.14001.57
WFC48.65-0.2700-0.55
JNJ130.39-0.3900-0.30
FB186.14-1.0500-0.56
GE9.32-0.0200-0.21
JPM118.70-1.5300-1.27
Earnings HistoryEstimateReportedSurprise %
Q04 2017--0.03-
Q04 2016--0.02-
Q03 2016-0.00-
Q02 2016--0.04-
Q01 2016--0.02-
Q04 2015--0.02-
Q03 2015--0.05-
Q02 2015--0.03-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Nov 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume54 547
Shares Outstanding (in ths.)10 059
Trades Count206
Dollar Volume174 321
Avg. Volume173 030
Avg. Weekly Volume129 918
Avg. Monthly Volume64 670
Avg. Quarterly Volume343 526
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
RatingStrong Buy
1.00
Strong Buy
1.00
-

Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products, are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

CEO: Jed A. Latkin

Teplephone: +1 614 793-7500

Address: 4995 Bradenton Avenue, Dublin 43017-3552, OH, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

47%53%

Bearish Bullish

53%47%

Bearish Bullish

59%41%

News